Development of synthetic surfactant and its protective effect on alveolar type II cell
Development of synthetic surfactant and its protective effect on alveolar type II cell
批准号:
15591621
负责人:
TASHIRO Katsumi
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
(1)Development of a synthetic surfactant protein. A synthetic peptide mimicking surfactant protein-C (Sp-C) was expressed in E.coli, by using pET80 vector and synthetic DNA. However, the yield of synthetic peptide was extremely low. Next, we tried to express the synthetic peptide as fusion proteins fused with DHPP protein using pQE40 vector and with tluoredoxin using pET32a. However, the yields were low in both cases. The low yield is thought to be because of high toxicity of the synthetic peptide to E.coli. So, we could not succeed in expressing synthetic peptide.(2)Protective of effect of hypercapnia. High concentration of carbon dioxide (suppressed the increase of TNF released from alveolar type II cell stimulated by IL-1 under cell culture. The levels of mRNA for inflammatory cytokine were not elevated. So, high concentration of carbon dioxide inhibits TNF release at the post-transcription level.(3)Effect of nicotine amide of lung ischemia rperfuusion injury. The left lung of adult rats was reperfirsed after 90 min of ischemia. The arterial oxygen pressure of rats given nicotinamide was 290±80 (SD) mmHg and was significantly higher than that of the control rat (about 100 mmHg). Nicotine amide significantly reduced the lung ischemia reperfusion injury.(4)Analysis of the lung expansion after surfactant impairment. Mechanical ventilation of immature newborn rabbits treated with surfactant mixed with serum causes the collapse of small alveoli and the overexpansion of large alveoli. However, this surfactant increased the tidal volume to the same extent as normal surfactant. Normal tidal volume dose not necessarily mean normal surfactant function and may lead to overlooking impaired surfactant function.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Over-distension and collapse of alveoli induced by serum-diluted surfactant (in Japanese)
血清稀释表面活性剂引起的肺泡过度扩张和塌陷(日语)
DOI:
--
发表时间:
2004
期刊:
Journal of Japanese Medical Society for Biological Interface 35
影响因子:
--
作者:
[Kobayashi T, Kabata C, Tashiro K, et al.]
通讯作者:
et al.
Tashiro K: "Modified protocols for surfactant therapy in experimental meconium aspiration syndrome."Biology of the Neonate. 83・1. 49-56 (2003)
Tashiro K:“实验性胎粪吸入综合征的表面活性剂治疗的修改方案。” 83・1 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Dextran improves function of syntheteic surfactant (in Japanese)
右旋糖酐改善合成表面活性剂的功能(日语)
DOI:
--
发表时间:
2003
期刊:
Journal of Japanese Medical Society for Biological Interface 34
影响因子:
--
作者:
[Tashiro K, Cui XG, Konzaki T et al.]
通讯作者:
Konzaki T et al.
血清で希釈されたサーファクタントによる肺胞の過伸展と虚脱
血清稀释的表面活性剂导致肺泡过度伸展和塌陷
DOI:
--
发表时间:
2004
期刊:
日本界面医学会雑誌 25・1
影响因子:
--
作者:
[小林勉, 加畑千春, 田代勝己 他]
通讯作者:
田代勝己 他
DOI:
10.1034/j.1399-6576.2003.00168.x
发表时间:
2003-08-01
期刊:
ACTA ANAESTHESIOLOGICA SCANDINAVICA
影响因子:
2.1
作者:
[Cui, XG, Tashiro, K, Kobayashi, T]
通讯作者:
Kobayashi, T
共 14 条
Developing artificial surfactant containing membrane-fusing substance and application for meconium aspiration syndrome
-
批准号:12671457
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:TASHIRO Katsumi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CircUSP19特异性调控Beclin1信号通路缓解禽E.coli诱导炎
症的机制解析
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
α-松油醇与美罗培南联用对 NDM-1 阳性 E.coli 的协同抗菌及机制研究
-
批准号:2024JJ7515
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:江超
-
依托单位:
肠道E.coli上调HDAC6促进神经元TDP-43胞浆聚集致POCD的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
代谢重编程E.coli Nissle治疗I型酪氨酸血症的作用及机制研究
-
批准号:82302092
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:顾鹏
-
依托单位:
Vidofludimus协同β-内酰胺类抗生素抗NDM-1阳性E.coli的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:张秀英
-
依托单位:
肠-肝轴:从MAFLD患者中分离的E.coli NF73-1作用于肠血管屏障对MAFLD进展的影响和机制研究
-
批准号:82100579
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:张一帆
-
依托单位:
犊牛腹泻病中E.coli肠道定植和肠黏膜屏障信号转导通路的蒙药及其有效成分的调理机理研究
-
批准号:32160817
-
项目类别:地区科学基金项目
-
资助金额:35万元
-
批准年份:2021
-
负责人:王纯洁
-
依托单位:
新lncRNA TLCD2-AS作为ceRNA通过TLR4/NF-κB信号通路调节E.coli型奶牛乳房炎的分子机制
-
批准号:32172709
-
项目类别:面上项目
-
资助金额:56万元
-
批准年份:2021
-
负责人:王兴平
-
依托单位:
二甲双胍通过激活AMPK通路拮抗E.coli性乳腺炎的分子机制研究
-
批准号:32102731
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:徐天乐
-
依托单位:
基于耗散结构的T/P-SAEW并联加工对E.coli协同杀菌效应熵驱动机制的动力学研究
-
批准号:32060573
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:和劲松
-
依托单位: